GlassScriptPhysician profile
William John Stout
NPI 1245263268
$1,721.20
in general payments reported to CMS, 2019-2025
27 companies · $63.39 in 2025
The $63.39 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $476 · 2023: $257 · 2024: $506 · 2025: $63.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $211.37 | 2021-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $190.69 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $127.00 | 2022 | |
| Astellas Pharma US INC | $109.18 | 2021-2024 | Myrbetriq, Xtandi |
| Progenics Pharmaceuticals, INC. | $107.59 | 2021-2024 | Pylarify |
| Convatec INC. | $106.10 | 2021-2024 | |
| Antares Pharma, INC. | $105.37 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $103.08 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $64.74 | 2021-2022 | |
| Blue Earth Diagnostics | $58.70 | 2022-2024 | |
| Dentsply Ih Ab | $57.14 | 2024 | Lofric |
| Immunitybio, INC. | $55.71 | 2024 | |
| Myovant Sciences INC. | $49.27 | 2021 | |
| Verity Pharmaceuticals INC. | $46.35 | 2022-2024 | Trelstar |
| Janssen Biotech, INC. | $45.55 | 2024 | Erleada, Akeega |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $39.22 | 2021 | |
| Urovant Sciences INC | $34.27 | 2022 | |
| Abc Home Medical Supply, INC. | $32.61 | 2024 | |
| Calyxo, INC. | $29.47 | 2024-2025 | Cvac Aspiration System |
| Teleflex LLC | $28.56 | 2021 | |
| Sun Pharmaceutical Industries INC. | $22.50 | 2022 | |
| Amgen INC. | $18.38 | 2021 | |
| Sumitomo Pharma America, INC. | $17.59 | 2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $15.95 | 2022 | |
| Acerus Pharmaceuticals Corporation | $15.65 | 2021 | |
| Urogen Pharma, INC. | $15.16 | 2023 | Jelmyto |
| Olympus America INC. | $14.00 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.